Table 5 Trigger times for drug-induced ocular adverse reactions.
From: Real world pharmacovigilance assessment of drug related macular degeneration risks
Drug | Median | Q1 | Q3 |
|---|---|---|---|
Alendronate sodium | 316 | 89 | 743 |
Amlodipine | 123 | 34 | 690 |
Anastrozole | 334 | 107 | 966 |
Budesonide | 20 | 4 | 31 |
Celecoxib | 109.5 | 5 | 757.5 |
Clopidogrel | 365 | 107 | 851 |
Conjugated estrogens | 2935.5 | 1224.25 | 9901.5 |
Crisaborole | 205 | 205 | 205 |
Exforge | 53.5 | 18.25 | 1396 |
Exemestane | 432 | 62 | 731 |
Exenatide | 106 | 28.5 | 366 |
Fluticasone furoate | 118 | 114 | 216.5 |
Fluticasone Propionate/salmeterol Xinafoate | 31 | 3 | 31 |
Hydroxychloroquine | 170.5 | 78 | 690.25 |
Ibandronate | 80 | 20 | 230.25 |
Imatinib | 180 | 46 | 622.75 |
Insulin detemir | 53 | 33 | 411 |
Insulin glargine | 276 | 153 | 516 |
Insulin human | 2231 | 365 | 4383 |
Insulin lispro | 1096 | 335 | 2922 |
Ipratropium bromide and albuterol | 730 | 478 | 742 |
Latanoprost | 202 | 29 | 895 |
Letrozole | 94 | 21 | 457 |
Levothyroxine | 2009 | 822.25 | 4863 |
Lifitegrast | 3 | 1 | 22 |
Nicotine | 3 | 2.5 | 6.5 |
Raloxifene | 396 | 114.5 | 1034 |
Risedronate | 42 | 9 | 244 |
Rivastigmine | 55 | 51 | 85 |
Rotigotine | 26.5 | 9.75 | 45 |
Simbrinza | 20 | 1.75 | 332 |
Sildenafil citrate | 350 | 41 | 1010 |
Tadalafil | 153 | 8 | 424 |
Tamoxifen | 556.5 | 182.5 | 1288 |
Tamsulosin | 536 | 285 | 1241.5 |
Teriparatide | 119 | 30 | 297.5 |
Tiotropium | 31 | 7 | 366 |
Tolterodine | 61 | 3.5 | 325.5 |
Travoprost | 18 | 3 | 157 |
Valsartan | 59.5 | 26.25 | 426.5 |
Vardenafil | 71 | 10.5 | 165 |
